Pacer Advisors Inc. decreased its stake in Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report) by 16.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,262 shares of the financial services provider’s stock after selling 9,714 shares during the quarter. Pacer Advisors Inc.’s holdings in Marsh & McLennan Companies were worth $10,251,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Carmichael Hill & Associates Inc. increased its stake in Marsh & McLennan Companies by 85.7% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 130 shares of the financial services provider’s stock worth $29,000 after buying an additional 60 shares in the last quarter. Catalyst Capital Advisors LLC bought a new position in Marsh & McLennan Companies in the 3rd quarter worth approximately $31,000. Albion Financial Group UT purchased a new stake in Marsh & McLennan Companies during the 4th quarter valued at approximately $38,000. Capital Performance Advisors LLP bought a new stake in shares of Marsh & McLennan Companies during the third quarter valued at approximately $41,000. Finally, Bangor Savings Bank bought a new position in shares of Marsh & McLennan Companies during the third quarter worth $46,000. 87.99% of the stock is owned by hedge funds and other institutional investors.
Marsh & McLennan Companies Trading Down 1.3 %
Shares of NYSE MMC opened at $220.84 on Wednesday. The firm has a market cap of $108.46 billion, a PE ratio of 27.20, a price-to-earnings-growth ratio of 2.27 and a beta of 0.96. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.89. Marsh & McLennan Companies, Inc. has a twelve month low of $189.90 and a twelve month high of $235.50. The business has a fifty day simple moving average of $218.00 and a two-hundred day simple moving average of $221.40.
Marsh & McLennan Companies Announces Dividend
Analyst Upgrades and Downgrades
A number of brokerages recently commented on MMC. UBS Group increased their price target on Marsh & McLennan Companies from $255.00 to $259.00 and gave the company a “buy” rating in a research note on Tuesday, October 22nd. Jefferies Financial Group boosted their target price on shares of Marsh & McLennan Companies from $219.00 to $222.00 and gave the stock a “hold” rating in a report on Wednesday, October 9th. JPMorgan Chase & Co. lifted their price target on Marsh & McLennan Companies from $230.00 to $235.00 and gave the stock a “neutral” rating in a research report on Friday, January 3rd. Keefe, Bruyette & Woods raised their price objective on Marsh & McLennan Companies from $212.00 to $214.00 and gave the company an “underperform” rating in a research note on Friday, January 10th. Finally, The Goldman Sachs Group set a $220.00 target price on Marsh & McLennan Companies and gave the company a “sell” rating in a research report on Friday, October 18th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, Marsh & McLennan Companies currently has an average rating of “Hold” and a consensus price target of $228.60.
View Our Latest Report on Marsh & McLennan Companies
Marsh & McLennan Companies Company Profile
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- Health Care Stocks Explained: Why You Might Want to Invest
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Stock Market Sectors: What Are They and How Many Are There?
- What Does the Future Hold for Eli Lilly?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Want to see what other hedge funds are holding MMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.